NOT-CA-18-045: Notice of Expiration of PAR-16-213 "Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21)"

Notice of Expiration of PAR-16-213 "Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21)"

Notice Number: NOT-CA-18-045

Key Dates
Release Date: January 23, 2018

Related Announcements
PAR-16-213

Issued by
National Cancer Institute (NCI)

Purpose

This Notice announces the expiration of PAR-16-213, "Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21)", effective January 24, 2018.

Inquiries

Please direct all inquiries to:

Jerry Suls, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6811
Email: [email protected]